Long only, deep value, special situations

Cellceutix: The Next Ten-Bagger Or Pie-In-The-Sky?

Cellceutix (OTCQB:CTIX) trades on the OTC Bulletin Board, with a market cap of $172M [for key stats, see yahoo] at the time of writing this. It has slightly under 100M shares outstanding and has traded in the last 3 months more or less between $1.50 and $2.30 judging by the charts [one has less confidence about the price figures for unlisted stocks]. The price, a year ago, was about 70¢/sh. What is behind such a rise is the interesting question, as well as where it is headed. Such a lofty valuation for a biotech firm that still has not published any clinical data on efficacy, has only $1M in cash, and has $2M in debt means that...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details